Cargando…

Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial

BACKGROUND: Cognitive behavioural therapy (CBT) is recommended for attention-deficit/hyperactivity-disorder (ADHD) in adolescents. However, all CBTs are not created equal, and the guidelines do not specify which CBT interventions are the most effective for this patient group. This study examines the...

Descripción completa

Detalles Bibliográficos
Autores principales: Haugan, Anne-Lise Juul, Sund, Anne Mari, Young, Susan, Thomsen, Per Hove, Lydersen, Stian, Nøvik, Torunn Stene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164353/
https://www.ncbi.nlm.nih.gov/pubmed/35655149
http://dx.doi.org/10.1186/s12888-022-04019-6
_version_ 1784720115729694720
author Haugan, Anne-Lise Juul
Sund, Anne Mari
Young, Susan
Thomsen, Per Hove
Lydersen, Stian
Nøvik, Torunn Stene
author_facet Haugan, Anne-Lise Juul
Sund, Anne Mari
Young, Susan
Thomsen, Per Hove
Lydersen, Stian
Nøvik, Torunn Stene
author_sort Haugan, Anne-Lise Juul
collection PubMed
description BACKGROUND: Cognitive behavioural therapy (CBT) is recommended for attention-deficit/hyperactivity-disorder (ADHD) in adolescents. However, all CBTs are not created equal, and the guidelines do not specify which CBT interventions are the most effective for this patient group. This study examines the efficacy of a group CBT without parent involvement as follow-up treatment compared to no additional CBT in adolescents with persistent and impairing ADHD symptoms after a short psychoeducational intervention and medical treatment. METHODS: The authors conducted a two-arm parallel randomized controlled trial in two child and adolescent mental health outpatient clinics in Norway. One hundred patients aged 14–18 years with a diagnosis of ADHD (66%) or subthreshold ADHD (34%) were randomized to either a 12-week group CBT program (N = 50) or a non-CBT control condition (N = 50). Assessments were made at admission to the clinic, two weeks before and two weeks after treatment. The primary outcomes were parent-, teacher- and self-ratings of ADHD symptoms (ADHD Rating Scale-IV), and the secondary outcomes were ratings of ADHD symptom severity, executive function, functional impairment, and emotional problems. Evaluators blinded to group allocation rated ADHD symptom severity with the Clinical Global Impression Scale for Severity (CGI-S) at baseline and post-treatment. RESULTS: Analyses using mixed-effects models showed no difference between the treatment arms from baseline to post treatment in primary and secondary outcomes. CONCLUSIONS: Contrary to our hypothesis, we found no incremental treatment effect on the part of a group CBT as follow-up to psychoeducation and pharmacological treatment on ADHD symptoms and accompanying impairments. Limitations with the CBT was the large number and low dosage of treatment components, causing restricted time for practice. Unlike evidence-based, individualized targeted CBTs with parent involvement, a group CBT directed solely at the adolescents with no parent involvement does not appear effective for treating ADHD. TRIAL REGISTRATION: NCT02937142, 18/10/2016. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-022-04019-6.
format Online
Article
Text
id pubmed-9164353
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91643532022-06-05 Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial Haugan, Anne-Lise Juul Sund, Anne Mari Young, Susan Thomsen, Per Hove Lydersen, Stian Nøvik, Torunn Stene BMC Psychiatry Research BACKGROUND: Cognitive behavioural therapy (CBT) is recommended for attention-deficit/hyperactivity-disorder (ADHD) in adolescents. However, all CBTs are not created equal, and the guidelines do not specify which CBT interventions are the most effective for this patient group. This study examines the efficacy of a group CBT without parent involvement as follow-up treatment compared to no additional CBT in adolescents with persistent and impairing ADHD symptoms after a short psychoeducational intervention and medical treatment. METHODS: The authors conducted a two-arm parallel randomized controlled trial in two child and adolescent mental health outpatient clinics in Norway. One hundred patients aged 14–18 years with a diagnosis of ADHD (66%) or subthreshold ADHD (34%) were randomized to either a 12-week group CBT program (N = 50) or a non-CBT control condition (N = 50). Assessments were made at admission to the clinic, two weeks before and two weeks after treatment. The primary outcomes were parent-, teacher- and self-ratings of ADHD symptoms (ADHD Rating Scale-IV), and the secondary outcomes were ratings of ADHD symptom severity, executive function, functional impairment, and emotional problems. Evaluators blinded to group allocation rated ADHD symptom severity with the Clinical Global Impression Scale for Severity (CGI-S) at baseline and post-treatment. RESULTS: Analyses using mixed-effects models showed no difference between the treatment arms from baseline to post treatment in primary and secondary outcomes. CONCLUSIONS: Contrary to our hypothesis, we found no incremental treatment effect on the part of a group CBT as follow-up to psychoeducation and pharmacological treatment on ADHD symptoms and accompanying impairments. Limitations with the CBT was the large number and low dosage of treatment components, causing restricted time for practice. Unlike evidence-based, individualized targeted CBTs with parent involvement, a group CBT directed solely at the adolescents with no parent involvement does not appear effective for treating ADHD. TRIAL REGISTRATION: NCT02937142, 18/10/2016. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-022-04019-6. BioMed Central 2022-06-02 /pmc/articles/PMC9164353/ /pubmed/35655149 http://dx.doi.org/10.1186/s12888-022-04019-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Haugan, Anne-Lise Juul
Sund, Anne Mari
Young, Susan
Thomsen, Per Hove
Lydersen, Stian
Nøvik, Torunn Stene
Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial
title Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial
title_full Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial
title_fullStr Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial
title_full_unstemmed Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial
title_short Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial
title_sort cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with adhd symptoms and related impairments: a randomised controlled trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164353/
https://www.ncbi.nlm.nih.gov/pubmed/35655149
http://dx.doi.org/10.1186/s12888-022-04019-6
work_keys_str_mv AT hauganannelisejuul cognitivebehaviouralgrouptherapyasadditiontopsychoeducationandpharmacologicaltreatmentforadolescentswithadhdsymptomsandrelatedimpairmentsarandomisedcontrolledtrial
AT sundannemari cognitivebehaviouralgrouptherapyasadditiontopsychoeducationandpharmacologicaltreatmentforadolescentswithadhdsymptomsandrelatedimpairmentsarandomisedcontrolledtrial
AT youngsusan cognitivebehaviouralgrouptherapyasadditiontopsychoeducationandpharmacologicaltreatmentforadolescentswithadhdsymptomsandrelatedimpairmentsarandomisedcontrolledtrial
AT thomsenperhove cognitivebehaviouralgrouptherapyasadditiontopsychoeducationandpharmacologicaltreatmentforadolescentswithadhdsymptomsandrelatedimpairmentsarandomisedcontrolledtrial
AT lydersenstian cognitivebehaviouralgrouptherapyasadditiontopsychoeducationandpharmacologicaltreatmentforadolescentswithadhdsymptomsandrelatedimpairmentsarandomisedcontrolledtrial
AT nøviktorunnstene cognitivebehaviouralgrouptherapyasadditiontopsychoeducationandpharmacologicaltreatmentforadolescentswithadhdsymptomsandrelatedimpairmentsarandomisedcontrolledtrial